PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
04-Dec-2025 Model N Launches Data nSights: Real-Time Analytics to Drive Action and Optimize Net Revenue Model N
04-Dec-2025 UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting UCB
04-Dec-2025 The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of pegcetacoplan for C3G and Primary IC-MPGN Sobi
04-Dec-2025 Clinigen targets validated by SBTi, setting verified path to Net-Zero Clinigen
04-Dec-2025 Vortex Launches Clinical Study Using Liquid Biopsy Technology to Advance Cancer Monitoring Vortex
04-Dec-2025 2026 set to be a milestone year for Qinecsa as drug safety tech trailblazer Beena Wood joins as Chief Product Officer Sarum Life Sciences
03-Dec-2025 Proscia Achieves SOC 2 Type II Certification, Strengthening Enterprise Trust Proscia
03-Dec-2025 Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates Brainomix
03-Dec-2025 Akiram Therapeutics: AKIR001 publication in The Journal of Nuclear Medicine supports ongoing clinical development Akiram Therapeutics
03-Dec-2025 Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer Actithera
03-Dec-2025 AlzeCure receives payment of EU grant for Phase 2 clinical trial with NeuroRestore ACD856 for Alzheimer's disease AlzeCure
02-Dec-2025 eXmoor Pharma and UCL forge a strategic collaboration to speed the advancement of cell and gene therapies eXmoor Pharma, UCL
02-Dec-2025 €150 million agreement between EIB and Angelini Ventures to finance European startups Angelini Ventures
02-Dec-2025 BiPER Therapeutics secures €1M investment to advance first-in-class cancer therapy into clinical trials BiPER Therapeutics
02-Dec-2025 BiPER Therapeutics secures €1M investment to advance first-in-class cancer therapy into clinical trials Andrew Lloyd Associates
02-Dec-2025 Axoltis Pharma raises €18 million to accelerate development of Amyotrophic Lateral Sclerosis (ALS) drug candidate Axoltis Pharma
02-Dec-2025 IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics IonQ, CCRM
02-Dec-2025 NADMED launches $30,000 award to accelerate breakthroughs in metabolomics research NADMED
02-Dec-2025 tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH tiakis Biotech AG
02-Dec-2025 Axoltis Pharma raises €18 million to accelerate development of Amyotrophic Lateral Sclerosis (ALS) drug candidate Andrew Lloyd Associates